The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.
Schwab Health Care SWHFX
- NAV / 1-Day Return 28.80 / +0.42 %
- Total Assets 838.0 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.790%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.73%
- Turnover 53%
USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 12:29 AM GMT+0
Morningstar’s Analysis SWHFX
Will SWHFX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 10.64 | 86.6 Mil | Healthcare |
Novo Nordisk A/S Class B | 5.87 | 47.8 Mil | Healthcare |
UnitedHealth Group Inc | 5.51 | 44.9 Mil | Healthcare |
AbbVie Inc | 4.76 | 38.8 Mil | Healthcare |
Merck & Co Inc | 4.74 | 38.6 Mil | Healthcare |
Johnson & Johnson | 3.76 | 30.7 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 3.68 | 30.0 Mil | Healthcare |
Stryker Corp | 3.56 | 29.0 Mil | Healthcare |
Amgen Inc | 2.97 | 24.2 Mil | Healthcare |
Novartis AG Registered Shares | 2.96 | 24.1 Mil | Healthcare |